Jefferson scientists deliver toxic genes to effectively kill pancreatic ca... ( PHILADELPHIA A research team led by...)

Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells

Date:9/23/2008

PHILADELPHIA A research team, led by investigators at the Department of Surgery at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has achieved a substantial "kill" of pancreatic cancer cells by using nanoparticles to successfully deliver a deadly diphtheria toxin gene. The findings set to be published in the October issue of Cancer Biology & Therapy reflect the first time this unique strategy has been tested in pancreatic cancer cells, and the success seen offers promise for future pre-clinical animal studies, and possibly, a new clinical approach.

The researchers found that delivery of a diphtheria toxin gene inhibited a basic function of pancreatic tumor cells by over 95 percent, resulting in significant cell death of pancreatic cancer cells six days after a single treatment. They also demonstrated that the treatment targets only pancreatic cancer cells and leaves normal cells alone, thus providing a potential 'therapeutic window.' Further, they are targeting a molecule that is found in over three-quarters of pancreatic cancer patients.

"For the pancreatic cancer world, this is very exciting," says the study's lead author, molecular biologist Jonathan Brody, Ph.D., assistant professor, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, who works closely with the Samuel D. Gross Professor and Surgeon, Charles J. Yeo, M.D. "There are no effective targeted treatments for pancreatic cancer, aside from surgery for which only a minority of patients qualify. We are in great need of translating the plethora of molecular information we know about this disease to novel therapeutic ideas."

Pancreatic cancer is the fourth leading cause of cancer-related mortality in the U.S., reflecting the generally short survival time of patients - often less than a year from diagnosis.

This approach was originally developed in ovarian cancer cells by stu
'/>"/>

Contact: Ed Federico
ed.federico@jefferson.edu
Thomas Jefferson University
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related biology news :

1. Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure
2. Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
3. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
4. ESA trains next generation of atmospheric scientists
5. Scientists find redesigned hammer that forged evolution of pregnancy in mammals
6. Scientists discover a new Pacific iguana
7. Scientists identify the genes that cause blindness produced by corneal edema
8. UNC scientists turn human skin cells into insulin-producing cells
9. Scientists isolate cancer stem cells
10. Scientists form alliance to develop nanotoxicology protocols
11. Scientists point to forests for carbon storage solutions

Post Your Comments:

(Date:2/9/2010)... Miami have analyzed images based on Synthetic Aperture ... Haiti,s earthquake, on January 12. The images reveal ... using data from Japan,s ALOS satellite and made ... of the European Space Agency (ESA) and GEO, ... of countries that promotes the exchange of satellite ...

(Date:2/9/2010)... People with anorexia nervosa, paradoxically, have strikingly high levels ... Children,s Hospital Boston. Their findings, based on MRI imaging ... 20 healthy girls of the same age, appear in ... and Mineral Research . , "It,s counter-intuitive that an ... be storing fat in her marrow," says endocrinologist Catherine ...

(Date:2/9/2010)... The Scripps Research Institute have discovered a potential new ... for sheep and cattle infected with liver fluke. The ... in combating river blindness, a tropical disease that is ... humans. , The study is scheduled for publication ... Proceedings of the National Academy of Sciences ...

Breaking Biology News(10 mins):New international satellite observations help assess future earthquake risk in Haiti 2 Anorexics found to have excess fat-- in their bone marrow 2 Scripps research team reveals how an old drug could have a new use for treating river blindness 2 Scripps research team reveals how an old drug could have a new use for treating river blindness 3 Scripps research team reveals how an old drug could have a new use for treating river blindness 4 GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 1 GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 2 GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 3 GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 4 New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 1 New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 2 New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 3 New Five Question Test Helps Assess Asthma Control in Children Under Five Years of Age 51784 4 Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 1 Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 2

[0] New international satellite observations help assess future earthquake risk in Haiti [0] Anorexics found to have excess fat-- in their bone marrow [0] Scripps research team reveals how an old drug could have a new use for treating river blindness

... prevent global warming, researchers and policymakers are exploring a ... carbon dioxide that reaches the atmosphere. One possible approach ... the source an electric power plant, for example ... theoretically promising, the technique has never been tested in ...

... or array that can quickly detect disorders such as Down ... effective tool in prenatal diagnosis in a series of 300 ... report that appears in the current issue of the journal ... led by Dr. Arthur Beaudet and Dr. Sau Wai Cheung ...

... properties of cancer cells are their ability to divide without ... establish new tumor sites. Now, researchers from the Mayo ... acts as a deadly master switch, both freeing cancer cells ... is potentially good news, say the researchers, who published their ...

Other Biology News:MIT: Safe storage of greenhouse-gas carbon dioxide 2 Microarray analysis improves prenatal diagnosis 2 Microarray analysis improves prenatal diagnosis 3 Mayo researchers identify dangerous 'two-faced' protein crucial to breast cancer spread and growth 2 Mayo researchers identify dangerous 'two-faced' protein crucial to breast cancer spread and growth 3

MIT: Safe storage of greenhouse-gas carbon dioxide Microarray analysis improves prenatal diagnosis Mayo researchers identify dangerous 'two-faced' protein crucial to breast cancer spread and growth

(Date:2/9/2010)... endpoint Clinical ( www.endpointclinical.com ), a ... (IWR) systems, announced today that PULSE, a fully ... deploy clinical trial Integrated Response Technology (IRT) systems, ... clinical trials. This time and cost savings stems ... developers do not have to spend valuable time ...

(Date:2/9/2010)... A leading clinical research center in ... study an investigational drug designed as a possible treatment ... affects between 45 and 90 percent of women of ... not life threatening, dysmenorrhea can be debilitating and psychologically ... absenteeism from work and school. ,, Current therapies for ...

(Date:2/9/2010)... BEACH, California and AMSTERDAM , ... in molecular cancer diagnostics, announced today that,it has ... New York State ,Department of Health. The ... to receive,commercial samples of MammaPrint, its FDA-cleared breast ... this latest permit, Agendia has now obtained all ...

(Date:2/9/2010)... February 9 ,, ... Microplasmin to Improve the Treatment,of a Range of ... ThromboGenics NV (Euronext Brussels: THR), a ... innovative treatments for eye,disease, vascular disease and cancer, ... results, evaluating the product,s efficacy and,safety in patients ...

Breaking Biology Technology:endpoint Saves Money and Time for Medical Research Teams Through PULSE 2 endpoint Saves Money and Time for Medical Research Teams Through PULSE 3 Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps 2 Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2 ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2 ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3 ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4

[0] endpoint Saves Money and Time for Medical Research Teams Through PULSE [0] Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps [0] Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists [0] ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology

... Training Center Scheduled to Open Friday, Feb. 29, ... Institute, LLC,will open its first training center in the ... local communities. Located in,Milipitas, CA, the center will be ... than 20 million Americans and costs the economy,$174 billion ...

... Continued year over year growth driven by Loestrin 24 ... Warner Chilcott,Limited (Nasdaq: WCRX ) today announced ... 2007. Revenue in the quarter ended December 31, 2007,totaled ... year quarter.,Revenue for the year ended December 31, 2007 ...

... today announced the submission of a supplemental New ... Administration (FDA) for once- daily,SEROQUEL XR(TM) (quetiapine fumarate) ... major depressive disorder (MDD) as,monotherapy, adjunct therapy, and ... 15 million American adults -- between 5 and ...

MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder

Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....

Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...

Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...

Request Info...

Biology Products:

Mouse Anti-Cig2 Monoclonal Antibody, Unconjugated, Clone CIG 3A11 / 5 from Abcam Mouse Anti-Myosin, heavy chain I, smooth muscle Monoclonal Antibody, Unconjugated, Clone 3F8 from Abcam Rabbit Anti-CAMK 1D beta Polyclonal Antibody, Unconjugated from Abcam Anti-Neurotensin Receptor Monoclonal Antibody, Unconjugated , Clone B-N6 from Cell Sciences

Jefferson scientists deliver toxic genes to effectively kill pancreatic ca...( PHILADELPHIA A research team led by...)